Measuring the Impact of Rotavirus Acute Gastroenteritis Episodes (MIRAGE): A prospective community-based study

Canadian Journal of Infectious Diseases and Medical Microbiology

Volumn 19, Issue 6, 2008, Pages 397-404

  Sénécal, Martin ^a   Brisson, Marc ^b,c   Lebel, Marc H ^d   Yaremko, John ^e   Wong, Richard ^f   Gallant, Lee Ann ^f   Garfield, Hartley A ^f   Ableman, Darryl J ^g   Ward, Richard L ^h   Sampalis, John S ^b,e,i,j   Mansi, James A ^a  

^a MERCK FROSST CENTRE FOR THERAPEUTIC RESEARCH   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c LAVAL UNIVERSITY   (Canada)

^d UNIVERSITY OF MONTREAL   (Canada)

^e MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^h CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

ⁱ JSS Medical Research   (Canada)

^j MCGILL UNIVERSITY   (Canada)

more..

Author keywords

Burden of illness; Gastroenteritis; Health care resource utilization; Rotavirus; Work loss

Indexed keywords

ANTIGEN;

ACUTE GASTROENTERITIS; ARTICLE; CANADA; CAREGIVER; CHILD; CLINICAL PRACTICE; CLINICAL TRIAL; COMMUNITY CARE; COMPARATIVE STUDY; CONTROLLED STUDY; DIARRHEA; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HEALTH CARE UTILIZATION; HOUSEHOLD; HUMAN; INCIDENCE; LOOSE FECES; MALE; MULTICENTER STUDY; OUTPATIENT DEPARTMENT; PARENTAL DEPRIVATION; PREVALENCE; PROSPECTIVE STUDY; QUESTIONNAIRE; REHYDRATION; ROTAVIRUS; SYMPTOM; TISSUE SECTION; VOMITING;

EID: 58149213969     PISSN: 17129532     EISSN: None     Source Type: Journal    
DOI: 10.1155/2008/451540     Document Type: Article

References (48)

1. Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003;9:565-72.
2. Clark B, McKendrick M. A review of viral gastroenteritis. Curr Opin Infect Dis 2004;17:461-9.
3. Fruhwirth M, Heininger U, Ehlken B, et al. International variation in disease burden of rotavirus gastroenteritis in children with community- and nosocomially acquired infection. Pediatr Infect Dis J 2001;20:784-91.
4. Fruhwirth M, Karmaus W, Moll-Schuler I, Brosl S, Mutz I. A prospective evaluation of community acquired gastroenteritis in paediatric practices: Impact and disease burden of rotavirus infection. Arch Dis Child 2001;84:393-7.
5. Leung AK, Kellner JD, Davies HD. Rotavirus gastroenteritis. Adv Ther 2005;22:476-87.
6. Raebel MA, Ou BS. Rotavirus disease and its prevention in infants and children. Pharmacotherapy 1999;19:1279-95.
7. Santos N, Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol 2005;15:29-56.
8. Ford-Jones EL, Mindorff CM, Gold R, Petric M. The incidence of viral-associated diarrhea after admission to a pediatric hospital. Am J Epidemiol 1990;131:711-8.
9. Staat MA, Azimi PH, Berke T, et al. Clinical presentations of rotavirus infection among hospitalized children. Pediatr Infect Dis J 2002;21:221-7.
10. Clark H, Offit P. Vaccines for rotavirus gastroenteritis universally needed for infants. Pediatr Ann 2004;33:536-43.
11. Franco MA, Angel J, Greenberg HB. Immunity and correlates of protection for rotavirus vaccines. Vaccine 2006;24:2718-31.
12. Girard MP, Steele D, Chaignat CL, Kieny MP. A review of vaccine research and development: Human enteric infections. Vaccine 2006;24:2732-50.
13. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006;354:11-22.
14. Van Damme P, Van der Wielen M, Ansaldi F, et al. Rotavirus vaccines: Considerations for successful implementation in Europe. Lancet Infect Dis 2006;6:805-12.
15. Van Damme P, Giaquinto C, Maxwell M, Todd P, Van der Wielen M. Distribution of rotavirus genotypes in Europe, 2004-2005: The REVEAL Study. J Infect Dis 2007;195(Suppl 1):S17-25.
16. Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006;354:23-33.
17. World Health Organization. State of the art of new vaccines research & development: Initiative for vaccine research. Geneva, Switzerland: World Health Organization, 2003.
18. Bresee JS, Glass RI, Ivanoff B, Gentsch JR. Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries. Vaccine 1999;17:2207-22.
19. Velazquez FR, Matson DO, Calva JJ, et al. Rotavirus infections in infants as protection against subsequent infections. N Engl J Med 1996;335:1022-8.
20. Chang HG, Glass RI, Smith PF, Cicirello HG, Holman RC, Morse DL. Disease burden and risk factors for hospitalizations associated with rotavirus infection among children in New York State, 1989 through 2000. Pediatr Infect Dis J 2003;22:808-14.
21. Coffin SE, Elser J, Marchant C, et al. Impact of acute rotavirus gastroenteritis on pediatric outpatient practices in the United States. Pediatr Infect Dis J 2006;25:584-9.
22. Fischer TK, Viboud C, Parashar U, et al. Hospitalizations and deaths from diarrhea and rotavirus among children <5 years of age in the United States, 1993-2003. J Infect Dis 2007;195:1117-25.
23. The Pediatric ROTavirus European CommitTee (PROTECT). The paediatric burden of rotavirus disease in Europe. Epidemiol Infect 2006;134:908-16.
24. Cascio A, Vizzi E, Alaimo C, Arista S. Rotavirus gastroenteritis in Italian children: Can severity of symptoms be related to the infecting virus? Clin Infect Dis 2001;32:1126-32.
25. Fischer TK. Incidence of hospitalizations due to rotavirus gastroenteritis in Denmark. Acta Paediatr 2001;90:1073-5.
26. Giaquinto C, Van Damme P, Huet F, et al. Clinical consequences of rotavirus acute gastroenteritis in Europe, 2004-2005: The REVEAL study. J Infect Dis 2007;195(Suppl 1):S26-35.
27. Giaquinto C, Van Damme P, Huet F, Gothefors L, Van der Wielen M. Costs of community-acquired pediatric rotavirus gastroenteritis in 7 European countries: The REVEAL Study. J Infect Dis 2007;195(Suppl 1):S36-44.
28. Gil A, Carrasco P, Jimenez R, San-Martin M, Oyaguez I, Gonzalez A. Burden of hospitalizations attributable to rotavirus infection in children in Spain, period 1999-2000. Vaccine 2004;22:2221-5.
29. Gleizes O, Desselberger U, Tatochenko V, et al. Nosocomial rotavirus infection in European countries: A review of the epidemiology, severity and economic burden of hospital-acquired rotavirus disease. Pediatr Infect Dis J 2006;25:S12-21.
30. Soriano-Gabarro M, Mrukowicz J, Vesikari T, Verstraeten T. Burden of rotavirus disease in European Union countries. Pediatr Infect Dis J 2006;25:S7-11.
31. Lynch M, O'Halloran F, Whyte D, Fanning S, Cryan B, Glass RI. Rotavirus in Ireland: National estimates of disease burden, 1997 to 1998. Pediatr Infect Dis J 2001;20:693-8.
32. Matson DO. On a multinational assessment of rotavirus disease in europe. J Infect Dis 2007;195(Suppl 1):S1-3.
33. Chen KT, Chen PY, Tang RB, et al. Sentinel hospital surveillance for rotavirus diarrhea in Taiwan, 2001-2003. J Infect Dis 2005;192(Suppl 1):S44-8.
34. Fischer TK, Anh DD, Antil L, et al. Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam. J Infect Dis 2005;192:1720-6.
35. Hsu VP, Abdul Rahman HB, Wong SL, et al. Estimates of the burden of rotavirus disease in Malaysia. J Infect Dis 2005;192(Suppl 1):S80-6.
36. Jiraphongsa C, Bresee JS, Pongsuwanna Y, et al. Epidemiology and burden of rotavirus diarrhea in Thailand: Results of sentinel surveillance. J Infect Dis 2005;192(Suppl 1):S87-93.
37. Nakagomi T, Nakagomi O, Takahashi Y, Enoki M, Suzuki T, Kilgore PE. Incidence and burden of rotavirus gastroenteritis in Japan, as estimated from a prospective sentinel hospital study. J Infect Dis 2005;192(Suppl 1):S106-10.
38. Nelson EA, Tam JS, Bresee JS, et al. Estimates of rotavirus disease burden in Hong Kong: Hospital-based surveillance. J Infect Dis 2005;192(Suppl 1):S71-9.
39. Nelson EA, Tam JS, Yu LM, et al. Hospital-based study of the economic burden associated with rotavirus diarrhea in Hong Kong. J Infect Dis 2005;192(Suppl 1):S64-70.
40. Nguyen VM, Nguyen VT, Huynh PL, et al. The epidemiology and disease burden of rotavirus in Vietnam: Sentinel surveillance at 6 hospitals. J Infect Dis 2001;183:1707-12.
41. Van Man N, Luan lT, Trach DD, et al. Epidemiological profile and burden of rotavirus diarrhea in Vietnam: 5 years of sentinel hospital surveillance, 1998-2003. J Infect Dis 2005;192(Suppl 1):S127-32.
42. Wang XY, Xu ZY, Von Seidlein L, et al. Incidence of diarrhea caused by rotavirus infections in rural Zhengding, China: Prospective, population-based surveillance. J Infect Dis 2005;192(Suppl 1):S100-5.
43. Ford-Jones EL, Wang E, Petric M, Corey P, Moineddin R, Fearon M. Hospitalization for community-acquired, rotavirus-associated diarrhea: A prospective, longitudinal, population-based study during the seasonal outbreak. The Greater Toronto Area/Peel Region PRESI Study Group. Pediatric Rotavirus Epidemiology Study for Immunization. Arch Pediatr Adolesc Med 2000;154:578-85.
44. Ford-Jones EL, Wang E, Petric M, Corey P, Moineddin R, Fearon M. Rotavirus-associated diarrhea in outpatient settings and child care centers. The Greater Toronto Area/Peel Region PRESI Study Group. Pediatric Rotavirus Epidemiology Study for Immunization. Arch Pediatr Adolesc Med 2000;154:586-93.
45. Rivest P, Proulx M, Lonergan G, Lebel MH, Bedard L. Hospitalisations for gastroenteritis: The role of rotavirus. Vaccine 2004;22:2013-7.
46. Ward RL, Bernstein DI, Young EC, Sherwood JR, Knowlton DR, Schiff GM. Human rotavirus studies in volunteers - determination of infectious dose and serological response to infection. J Infect Dis 1986;154:871-80.
47. Gilchrist MJ, Bretl TS, Moultney K, Knowlton DR, Ward RL. Comparison of seven kits for detection of rotavirus in fecal specimens with a sensitive, specific enzyme immunoassay. Diagn Microbiol Infect Dis 1987;8:221-8.
48. Jacobs P, Shane LG, Fassbender K, Wang EL, Moineddin R, Ford-Jones EL. Economic analysis of rotavirus-associated diarrhea in the metropolitan Toronto and Peel regions of Ontario. Can J Infect Dis 2002;13:167-74.